{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:59:30Z","timestamp":1790049570775,"version":"4.0.1"},"reference-count":36,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T00:00:00Z","timestamp":1544659200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1210\/js.2018-00343","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T19:04:04Z","timestamp":1544641444000},"page":"284-290","source":"Crossref","is-referenced-by-count":13,"title":["Case Report of an Adrenocortical Carcinoma Associated With Germline CHEK2 Mutation"],"prefix":"10.1210","volume":"3","author":[{"given":"Changqing","family":"Xie","sequence":"first","affiliation":[{"name":"Medical Oncology Service, Center for Cancer Research, National Cancer Institute, Clinical Center, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Tanakchi","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, Clinical Center, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Raygada","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Clinical Center, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy L","family":"Davis","sequence":"additional","affiliation":[{"name":"Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9710-4030","authenticated-orcid":false,"given":"Jaydira","family":"Del Rivero","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Clinical Center, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"issue":"12","key":"2019041122570437500_B1","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2013-3020","article-title":"Update in adrenocortical carcinoma","volume":"98","author":"Fassnacht","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041122570437500_B2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.17925\/EE.2018.14.2.62","article-title":"Role of mitotane in adrenocortical carcinoma - review and state of the art","volume":"14","author":"Paragliola","year":"2018","journal-title":"Eur Endocrinol"},{"issue":"2","key":"2019041122570437500_B3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"issue":"6","key":"2019041122570437500_B4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1530\/EJE-13-0519","article-title":"Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center","volume":"169","author":"Ayala-Ramirez","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2019041122570437500_B5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40618-013-0049-2","article-title":"Management of adrenal cancer: a 2013 update","volume":"37","author":"Terzolo","year":"2014","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2019041122570437500_B6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MED.0b013e3282fdf4c0","article-title":"Adjunctive treatment of adrenocortical carcinoma","volume":"15","author":"Terzolo","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"2019041122570437500_B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2012.04403.x","article-title":"Genetic aspects of adrenocortical tumours and hyperplasias","volume":"77","author":"Mazzuco","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"23","key":"2019041122570437500_B8","doi-asserted-by":"crossref","first-page":"e10894","DOI":"10.1097\/MD.0000000000010894","article-title":"Germline mutation of CHEK2 in neurofibromatosis 1 and 2: two case reports","volume":"97","author":"Li","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2019041122570437500_B9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/gcc.22503","article-title":"Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer","volume":"57","author":"Wang","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"issue":"12","key":"2019041122570437500_B10","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1053\/hupa.2000.20409","article-title":"Adrenocortical adenocarcinoma in an MSH2 carrier: coincidence or causal relation","volume":"31","author":"Berends","year":"2000","journal-title":"Hum Pathol"},{"issue":"8","key":"2019041122570437500_B11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/modpathol.3800150","article-title":"Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome","volume":"17","author":"Broaddus","year":"2004","journal-title":"Mod Pathol"},{"issue":"2","key":"2019041122570437500_B12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10689-010-9416-8","article-title":"Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome","volume":"10","author":"Medina-Arana","year":"2011","journal-title":"Fam Cancer"},{"issue":"5","key":"2019041122570437500_B13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/EJE-17-0358","article-title":"Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series","volume":"177","author":"Else","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2019041122570437500_B14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00580-017-2455-x","article-title":"An association study between CHEK2 gene mutations and susceptibility to breast cancer","volume":"26","author":"Jalilvand","year":"2017","journal-title":"Comp Clin Pathol"},{"issue":"43","key":"2019041122570437500_B15","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1038\/sj.onc.1209877","article-title":"The CHEK2 gene and inherited breast cancer susceptibility","volume":"25","author":"Nevanlinna","year":"2006","journal-title":"Oncogene"},{"issue":"1","key":"2019041122570437500_B16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10549-008-0249-1","article-title":"Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk","volume":"117","author":"Serrano-Fern\u00e1ndez","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2019041122570437500_B17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1101\/gad.14.3.278","article-title":"Chk2\/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53","volume":"14","author":"Chehab","year":"2000","journal-title":"Genes Dev"},{"issue":"1","key":"2019041122570437500_B18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng879","article-title":"Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations","volume":"31","author":"Meijers-Heijboer","year":"2002","journal-title":"Nat Genet"},{"issue":"11","key":"2019041122570437500_B19","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jmg.2006.044974","article-title":"A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer","volume":"43","author":"Cybulski","year":"2006","journal-title":"J Med Genet"},{"issue":"3","key":"2019041122570437500_B20","doi-asserted-by":"crossref","first-page":"E476","DOI":"10.1210\/jc.2011-1982","article-title":"TP53 germline mutations in adult patients with adrenocortical carcinoma","volume":"97","author":"Herrmann","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5449","key":"2019041122570437500_B21","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1126\/science.286.5449.2528","article-title":"Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome","volume":"286","author":"Bell","year":"1999","journal-title":"Science"},{"issue":"1","key":"2019041122570437500_B22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/gcc.1207","article-title":"Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors","volume":"33","author":"Miller","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"2019041122570437500_B23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1086\/346094","article-title":"Mutations in CHEK2 associated with prostate cancer risk","volume":"72","author":"Dong","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2019041122570437500_B24","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/426403","article-title":"CHEK2 is a multiorgan cancer susceptibility gene","volume":"75","author":"Cybulski","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"4","key":"2019041122570437500_B25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1200\/JCO.2007.12.5922","article-title":"CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls","volume":"26","author":"Weischer","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019041122570437500_B26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ijc.11384","article-title":"CHEK2 1100delC is not a risk factor for male breast cancer population","volume":"108","author":"Syrj\u00e4koski","year":"2004","journal-title":"Int J Cancer"},{"issue":"2","key":"2019041122570437500_B27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.canlet.2004.07.002","article-title":"Analysis of familial male breast cancer for germline mutations in CHEK2","volume":"215","author":"Sodha","year":"2004","journal-title":"Cancer Lett"},{"issue":"2","key":"2019041122570437500_B28","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1086\/341943","article-title":"A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer","volume":"71","author":"Vahteristo","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"5","key":"2019041122570437500_B29","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1086\/375121","article-title":"The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype","volume":"72","author":"Meijers-Heijboer","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"10","key":"2019041122570437500_B30","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/jmg.2004.019737","article-title":"Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant","volume":"41","author":"de Bock","year":"2004","journal-title":"J Med Genet"},{"issue":"12","key":"2019041122570437500_B31","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1158\/1055-9965.EPI-06-0687","article-title":"A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers","volume":"15","author":"Thompson","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"2019041122570437500_B32","doi-asserted-by":"crossref","first-page":"a026179","DOI":"10.1101\/cshperspect.a026179","article-title":"Somatic TP53 mutations in the era of genome sequencing","volume":"6","author":"Hainaut","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5459","key":"2019041122570437500_B33","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1126\/science.287.5459.1824","article-title":"DNA damage-induced activation of p53 by the checkpoint kinase Chk2","volume":"287","author":"Hirao","year":"2000","journal-title":"Science"},{"issue":"1","key":"2019041122570437500_B34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1897-4287-7-4","article-title":"The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype","volume":"7","author":"Ruijs","year":"2009","journal-title":"Hered Cancer Clin Pract"},{"issue":"1","key":"2019041122570437500_B35","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2012-2198","article-title":"Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma","volume":"98","author":"Raymond","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041122570437500_B36","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/3\/1\/284\/27386765\/js.2018-00343.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T03:25:02Z","timestamp":1662607502000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/3\/1\/284\/5239842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,12]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12,12]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/js.2018-00343","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,12,12]]}}}